Browse > Article

Treatment of Carcinoma in Situ of Glottis by KTP Fiberoptic Laryngeal Laser Surgery Under Local Anesthesia  

Lee, Yun Ji (Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon Hospital)
Lee, Eunsang (Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon Hospital)
Park, Ki Nam (Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon Hospital)
Lee, Seung Won (Department of Otorhinolaryngology-Head and Neck Surgery, Soonchunhyang University College of Medicine, Bucheon Hospital)
Publication Information
Journal of the Korean Society of Laryngology, Phoniatrics and Logopedics / v.30, no.1, 2019 , pp. 53-56 More about this Journal
Abstract
The optimal treatments of carcinoma in situ of glottis include radiotherapy, laser surgery and vertical partial laryngectomy. Conventional surgical treatments need general anesthesia and radiotherapy has several complications. Recently, the effectiveness of 532 nm potassium titanyl phosphate (KTP) laser has been proven and widely used in vocal fold diseases even some cases of vocal fold dysplasia. A patient with difficult laryngeal exposure underwent fiberoptic laryngeal laser surgery using KTP laser under local anesthesia, showed improved voice outcome and the glottic lesion was removed successfully without local recurrence and regional metastasis 18 months after surgery.
Keywords
Carcinoma in situ; Difficult laryngeal exposure; Fiberoptic laryngeal laser surgery;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Ohno S, Hirano S, Tateya I, Kojima T, Ito J. Management of vocal fold lesions in difficult laryngeal exposure patients in phonomicrosurgery. Auris Nasus Larynx 2011;38(3):373-80.   DOI
2 Xie X, Young J, Kost K, McGregor M. KTP 532 nm laser for laryngeal lesions. a systematic review. J Voice 2013;27(2):245-9.   DOI
3 Zeitels SM, Burns JA. Oncologic efficacy of angiolytic KTP laser treatment of early glottic cancer. Ann Otol Rhinol Laryngol 2014;123(12):840-6.   DOI
4 Le QT, Takamiya R, Shu HK, Smitt M, Singer M, Terris DJ, et al. Treatment results of carcinoma in situ of the glottis: an analysis of 82 cases. Arch Otolaryngol Head Neck Surg 2000;126(11):1305-12.   DOI
5 Park JH, Paeng JP, Na HS, Lim KJ, Kwon SY, Jung KY, et al. Treatment results of laser cordectomy and radiation therapy for early glottic cancer. Korean J Otolaryngol Head Neck Surg 2002;45(2):159-63.
6 Friedman AD, Hillman RE, Landau-Zemer T, Burns JA, Zeitels SM. Voice outcomes for photoangiolytic KTP laser treatment of early glottic cancer. Ann Otol Rhinol Laryngol 2013;122(3):151-8.   DOI
7 Zeitels SM, Burns JA, Lopez-Guerra G, Anderson RR, Hillman RE. Photoangiolytic laser treatment of early glottic cancer: a new management strategy. Ann Otol Rhinol Laryngol Suppl 2008;199:3-24.
8 Piazza C, Paderno A, Grazioli P, Del Bon F, Montalto N, Perotti P, et al. Laryngeal exposure and margin status in glottic cancer treated by transoral laser microsurgery. Laryngoscope 2018;128(5):1146-51.   DOI
9 Hirano S, Yamashita M, Kitamura M, Takagita S. Photocoagulation of microvascular and hemorrhagic lesions of the vocal fold with the KTP laser. Ann Otol Rhinol Laryngol 2006;115(4):253-9.   DOI
10 Zeitels SM, Akst LM, Burns JA, Hillman RE, Broadhurst MS, Anderson RR. Office-based 532-nm pulsed KTP laser treatment of glottal papillomatosis and dysplasia. Ann Otol Rhinol Laryngol 2006;115(9):679-85.   DOI